The Chinese University of Hong Kong (CUHK) has set up its first clinical trial centre outside Hong Kong, teaming up with mainland Chinese authorities to strengthen research collaboration and help develop the Greater Bay Area into an international hub for medical innovation.
The Greater Bay Area Clinical Trial Centre, located at the Nansha branch of Guangzhou First People’s Hospital, was established on Wednesday as representatives from the university, Nansha District authorities and the hospital signed a collaboration agreement.
The centre aims to improve clinical research capabilities and healthcare quality across the region, as well as speed up the development and adoption of innovative pharmaceuticals and medical technologies to benefit more patients in the bay area.
The first batch of studies at the facility will focus on artificial-intelligence-powered scoliosis screening and stem cell therapy for knee osteoarthritis.
“Through the efforts of all three parties, the centre will be an important platform to advance regional clinical research innovation,” said CUHK pro-vice-chancellor Professor Anthony Chan Tak-cheung at a ceremony in Nansha.
“It will conduct research on pharmaceuticals and medical devices in accordance with national regulations and international standards, advance multicentre, cross-boundary and cross-regional collaboration, and provide a systematic platform for talent development and academic exchange.”